Development and evaluation of a decision Aid for BRCA carriers with breast cancer

37Citations
Citations of this article
115Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

BRCA+ breast cancer patients face high risk for a second breast cancer and ovarian cancer. Helping these women decide among risk-reducing options requires effectively conveying complex, emotionally-laden, information. To support their decision-making needs, we developed a web-based decision aid (DA) as an adjunct to genetic counseling. Phase 1 used focus groups to determine decision-making needs. These findings and the Ottawa Decision Support Framework guided the DA development. Phase 2 involved nine focus groups of four stakeholder types (BRCA+ breast cancer patients, breast cancer advocates, and genetics and oncology professionals) to evaluate the DA's decision-making utility, information content, visual display, and implementation. Overall, feedback was very favorable about the DA, especially a values and preferences ranking-exercise and an output page displaying personalized responses. Stakeholders were divided as to whether the DA should be offered at-home versus only in a clinical setting. This well-received DA will be further tested to determine accessibility and effectiveness. © 2011 National Society of Genetic Counselors, Inc.

Cite

CITATION STYLE

APA

Culver, J. O., MacDonald, D. J., Thornton, A. A., Sand, S. R., Grant, M., Bowen, D. J., … Weitzel, J. N. (2011). Development and evaluation of a decision Aid for BRCA carriers with breast cancer. Journal of Genetic Counseling, 20(3), 294–307. https://doi.org/10.1007/s10897-011-9350-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free